Biopharmaceuticals and Biotherapeutics: Recent Advancements

Over the past two decades there has been a decisive shift towards large molecule, biological drugs or biopharmaceuticals, and away from traditional chemically synthesised, small molecule drugs Revenue from biopharmaceuticals in 2016 was in the range of $280-300 billion and is forecasted to grow at about 10% for the foreseeable future. One particular biomolecule dominates though in biopharmaceuticals currently and that is the monoclonal antibody.

The number approved for use as biopharmaceuticals has steadily increased and in 2016 accounted for five of the top ten selling drugs globally with revenues of $46 billion

This appetite for monoclonal drugs shows no sign of abating with this article on the therapeutic monoclonal antibody market anticipating 2020 revenues of $125 billion. A recent FiercePharma report also predicted that by 2022 monoclonal antibodies will make up 60% of the top selling cancer drugs.

A biologic therapeutic product, also known as a biologic, is a therapeutic product developed to treat a variety of diseases. This biologic product can be a monoclonal antibody, a vaccine, a tissue, or various proteins such as cytokines, enzymes, fusion proteins, whole cells, and viral and nonviral gene therapies

  • Cell-based therapeutics
  • Biopharmaceutical and Drug Delivery
  • Biotherapeutics
  • Biomedical proteins

Related Conference of Biopharmaceuticals and Biotherapeutics: Recent Advancements

December 01-02, 2025

13th International Conference on Clinical Trials

Vancouver, Canada
January 29-30, 2026

19th World Drug Delivery Summit

Paris, France
February 10-11, 2026

40th World Congress on Pharmacology and Therapeutics

Barcelona, Spain
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, UK
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
March 24-25, 2026

11th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
April 16-17, 2026

19th European Biosimilars Congress

Rome, Italy
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France

Biopharmaceuticals and Biotherapeutics: Recent Advancements Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in